Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

Treatment with oral melphalan and dexamethasone (M-Dex) was reported to be effective and feasible in patients with systemic light chain amyloidosis (AL) not eligible for high-dose melphalan. We report on 61 patients with advanced AL who were treated with intravenous M-Dex as first-line therapy. Esti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dietrich, Sascha (VerfasserIn) , Schönland, Stefan (VerfasserIn) , Benner, Axel (VerfasserIn) , Bochtler, Tilmann (VerfasserIn) , Kristen, Arnt (VerfasserIn) , Beimler, Jörg (VerfasserIn) , Hund, Ernst (VerfasserIn) , Zorn, Markus (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Hegenbart, Ute (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [29 July 2010]
In: Blood
Year: 2010, Jahrgang: 116, Heft: 4, Pages: 522-528
ISSN:1528-0020
DOI:10.1182/blood-2009-11-253237
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2009-11-253237
Volltext
Verfasserangaben:Sascha Dietrich, Stefan O. Schönland, Axel Benner, Tilmann Bochtler, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Hartmut Goldschmidt, Antony D. Ho, and Ute Hegenbart

MARC

LEADER 00000caa a2200000 c 4500
001 1785235257
003 DE-627
005 20230426205548.0
007 cr uuu---uuuuu
008 220107s2010 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2009-11-253237  |2 doi 
035 |a (DE-627)1785235257 
035 |a (DE-599)KXP1785235257 
035 |a (OCoLC)1341436839 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dietrich, Sascha  |d 1979-  |e VerfasserIn  |0 (DE-588)136406300  |0 (DE-627)694354635  |0 (DE-576)301003408  |4 aut 
245 1 0 |a Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement  |c Sascha Dietrich, Stefan O. Schönland, Axel Benner, Tilmann Bochtler, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Hartmut Goldschmidt, Antony D. Ho, and Ute Hegenbart 
264 1 |c [29 July 2010] 
300 |b Diagramme 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.01.2022 
520 |a Treatment with oral melphalan and dexamethasone (M-Dex) was reported to be effective and feasible in patients with systemic light chain amyloidosis (AL) not eligible for high-dose melphalan. We report on 61 patients with advanced AL who were treated with intravenous M-Dex as first-line therapy. Estimated median overall survival (OS) was 17.5 months. Seventeen patients (28%) died within 3 months, mostly of disease-related complications. In addition, nonhematologic toxicity of Common Terminology Criteria grade 3 or 4 was observed in 20 patients, whereas hematologic toxicity was low. Twenty-seven patients (44%) had hematologic response, including complete in 7 patients (11%) and partial remission in 20 patients (33%). Organ response was observed in 15 patients (25%). The amount of the involved free light chains in serum and Karnofsky Index at diagnosis significantly influenced OS. Plasma levels of the cardiac biomarkers before start of treatment and their increase after the third M-Dex cycle also were strong negative predictors of OS. These parameters might help to identify patients who will not benefit from M-Dex chemotherapy. 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Bochtler, Tilmann  |d 1975-  |e VerfasserIn  |0 (DE-588)128398957  |0 (DE-627)372639925  |0 (DE-576)187323909  |4 aut 
700 1 |a Kristen, Arnt  |d 1974-  |e VerfasserIn  |0 (DE-588)123480965  |0 (DE-627)706314530  |0 (DE-576)293726876  |4 aut 
700 1 |a Beimler, Jörg  |d 1968-  |e VerfasserIn  |0 (DE-588)115360417  |0 (DE-627)691258740  |0 (DE-576)289834899  |4 aut 
700 1 |a Hund, Ernst  |e VerfasserIn  |0 (DE-588)17352799X  |0 (DE-627)698439953  |0 (DE-576)134372603  |4 aut 
700 1 |a Zorn, Markus  |d 1964-  |e VerfasserIn  |0 (DE-588)1033873721  |0 (DE-627)745111483  |0 (DE-576)381543137  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 116(2010), 4, Seite 522-528  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement 
773 1 8 |g volume:116  |g year:2010  |g number:4  |g pages:522-528  |g extent:7  |a Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement 
856 4 0 |u https://doi.org/10.1182/blood-2009-11-253237  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220107 
993 |a Article 
994 |a 2010 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 11  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 9 
998 |g 1033873721  |a Zorn, Markus  |m 1033873721:Zorn, Markus  |d 910000  |d 910100  |e 910000PZ1033873721  |e 910100PZ1033873721  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 17352799X  |a Hund, Ernst  |m 17352799X:Hund, Ernst  |d 50000  |e 50000PH17352799X  |k 0/50000/  |p 7 
998 |g 115360417  |a Beimler, Jörg  |m 115360417:Beimler, Jörg  |d 910000  |d 910100  |e 910000PB115360417  |e 910100PB115360417  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 123480965  |a Kristen, Arnt  |m 123480965:Kristen, Arnt  |d 910000  |d 910100  |e 910000PK123480965  |e 910100PK123480965  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 128398957  |a Bochtler, Tilmann  |m 128398957:Bochtler, Tilmann  |d 910000  |d 910100  |e 910000PB128398957  |e 910100PB128398957  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 3 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |e 910000PS122405226  |e 910100PS122405226  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 136406300  |a Dietrich, Sascha  |m 136406300:Dietrich, Sascha  |d 910000  |d 910100  |e 910000PD136406300  |e 910100PD136406300  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1785235257  |e 4031245122 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Sascha","family":"Dietrich","display":"Dietrich, Sascha"},{"given":"Stefan","role":"aut","family":"Schönland","display":"Schönland, Stefan"},{"family":"Benner","display":"Benner, Axel","role":"aut","given":"Axel"},{"given":"Tilmann","role":"aut","family":"Bochtler","display":"Bochtler, Tilmann"},{"family":"Kristen","display":"Kristen, Arnt","role":"aut","given":"Arnt"},{"display":"Beimler, Jörg","family":"Beimler","role":"aut","given":"Jörg"},{"family":"Hund","display":"Hund, Ernst","given":"Ernst","role":"aut"},{"role":"aut","given":"Markus","family":"Zorn","display":"Zorn, Markus"},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","given":"Hartmut","role":"aut"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"},{"display":"Hegenbart, Ute","family":"Hegenbart","role":"aut","given":"Ute"}],"language":["eng"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"[29 July 2010]"}],"note":["Gesehen am 07.01.2022"],"title":[{"title_sort":"Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement","title":"Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1785235257","relHost":[{"title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-"}],"pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"disp":"Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvementBlood","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]},"corporate":[{"role":"isb","display":"American Society of Hematology"}],"language":["eng"],"part":{"volume":"116","extent":"7","text":"116(2010), 4, Seite 522-528","issue":"4","pages":"522-528","year":"2010"},"titleAlt":[{"title":"Blood online"}]}],"name":{"displayForm":["Sascha Dietrich, Stefan O. Schönland, Axel Benner, Tilmann Bochtler, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Hartmut Goldschmidt, Antony D. Ho, and Ute Hegenbart"]},"physDesc":[{"extent":"7 S.","noteIll":"Diagramme"}],"id":{"doi":["10.1182/blood-2009-11-253237"],"eki":["1785235257"]}} 
SRT |a DIETRICHSATREATMENTW2920